Tilray Brands, Inc. (TLRY)
8.09
+0.89
(+12.36%)
USD |
NASDAQ |
Dec 09, 16:00
8.03
-0.06
(-0.74%)
After-Hours: 20:00
Tilray Brands EPS Diluted (Quarterly): -0.0003 for Aug. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2491 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.513M |
| Revenue (Quarterly) | 209.50M |
| Total Expenses (Quarterly) | 209.82M |
| Enterprise Value | 977.27M |
| Gross Profit Margin (Quarterly) | 25.56% |
| Profit Margin (Quarterly) | 0.72% |
| Earnings Yield | -28.05% |
| Normalized Earnings Yield | -8.465 |